A proposed mechanism for diabetic cardiomyopathy is the deposition of collagen in the ECM due to increased expression of tumor necrosis factor-beta (TGF-β), and connective tissue growth factor and decreased expression of matrix metalloproteinases [21,22,23]. Here, CCN2 is linked to diabetic cardiomyopathy.